Enwei Pharmaceutical Co., Ltd. (SHE:301331)
China
· Delayed Price · Currency is CNY 28.57
+0.72 (2.59%)
At close: Mar 10, 2026
Enwei Pharmaceutical Company Description
Enwei Pharmaceutical Co., Ltd. engages in the development and sale of Chinese medicines in China.
The company offers drugs in the areas of gynecology, pediatrics, and respiratory system fields. The company was founded in 2005 and is based in Chengdu, China.
Enwei Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 2005 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,548 |
| CEO | Yongjiang Xue |
Contact Details
Address: No. 458, Shuanghua Road Chengdu, 610200 China | |
| Phone | 86 28 8154 8888 |
| Website | enwei.com.cn |
Stock Details
| Ticker Symbol | 301331 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Yongjiang Xue | Chairman and Chief Executive Officer |
| Xue Gang | Vice Chairman and President |
| Dawei Hu | Chief Financial Officer, Vice President and Secretary of the Board |
| Zhuang Yan | Vice President and Director |
| Lei Chen | Vice President |
| Hui Ning | Accounting Supervisor |